glp-1 receptor agonist nephrolithiasis Role of Agonists & SGLT-2 Inhibitors in Kidney Care The Impact of GLP-1 Receptor

A pharmacological elevation of GLP-1 is able to restore insulin secretion in type 2 diabetes (6)

N Engl J Med 2023;389:106984

monthly injections)

Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study BMJ 2026

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: From randomised trials to clinical practice

All three amylin products appear to have the potential to challenge tirzepatide on an efficacy/tolerability basis, so it will be interesting to see how Novo Nordisk and Eli Lilly position these products alongside their current GLP-1 offerings